{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:28:43Z","timestamp":1787765323572,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T00:00:00Z","timestamp":1478476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Deregulated IGF-1R-AKT signaling influences multiple nodes of cancer cell physiology and assists in migration, metastasis and acquirement of radio\/chemoresistance. Enrichment of cancer stem cells (CSC) positively correlates with radio\/chemoresistance development in various malignancies. It is unclear though, how IGF-1R-AKT signalling shapes CSC functionality especially in ovarian cancer. Previously we showed that upregulated IGF-1R expression is essential to initiate platinum-taxol resistance at early stage which declines with elevated levels of activated AKT at late resistant stage in ovarian cancer cells. Here, we investigated the effect of this oscillatory IGF-1R-AKT signalling upon CSC functionality during generation of chemoresistance. While gradual increase in CSC properties from early (ER) to late (LR) resistant stages was observed in three different (cisplatin\/paclitaxel\/cisplatin-paclitaxel) cellular models created in two ovarian cancer cell lines, the stemness gene expressions (<jats:italic>oct4<\/jats:italic>\/<jats:italic>sox2<\/jats:italic>\/<jats:italic>nanog<\/jats:italic>) reached a plateau at early resistant stages. Inhibition of IGF-1R only at ER and AKT inhibition only at LR stages significantly abrogated the CSC phenotype. Interestingly, real time bioluminescence imaging showed CSCs of ER stages possessed faster tumorigenic potential than CSCs belonging to LR stages. Together, our data suggest that IGF-1R-AKT signalling imparts functional heterogeneity in CSCs during acquirement of chemoresistance in ovarian carcinoma.<\/jats:p>","DOI":"10.1038\/srep36612","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T10:41:11Z","timestamp":1478515271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population"],"prefix":"10.1038","volume":"6","author":[{"given":"Ram K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Dhadve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Sakpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"BFsrep36612_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3324\/haematol.2009.010785","volume":"95","author":"N Chapuis","year":"2010","unstructured":"Chapuis, N. et al. Autocrine IGF-1\/IGF-1R signaling is responsible for constitutive PI3K\/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica 95, 415\u2013423, doi: 10.3324\/haematol.2009.010785 (2010).","journal-title":"Haematologica"},{"key":"BFsrep36612_CR2","doi-asserted-by":"publisher","first-page":"29912","DOI":"10.1074\/jbc.M504516200","volume":"280","author":"J Chen","year":"2005","unstructured":"Chen, J. et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. The Journal of biological chemistry 280, 29912\u201329920, doi: 10.1074\/jbc.M504516200 (2005).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep36612_CR3","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1158\/1078-0432.CCR-07-4879","volume":"14","author":"MM Chitnis","year":"2008","unstructured":"Chitnis, M. M., Yuen, J. S., Protheroe, A. S., Pollak, M. & Macaulay, V. M. The type 1 insulin-like growth factor receptor pathway. Clinical cancer research: an official journal of the American Association for Cancer Research 14, 6364\u20136370, doi: 10.1158\/1078-0432.CCR-07-4879 (2008).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep36612_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/excr.1999.4667","volume":"253","author":"R Baserga","year":"1999","unstructured":"Baserga, R. The IGF-I receptor in cancer research. Experimental cell research 253, 1\u20136, doi: 10.1006\/excr.1999.4667 (1999).","journal-title":"Experimental cell research"},{"key":"BFsrep36612_CR5","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/0008-5472.CAN-08-3153","volume":"69","author":"N Eckstein","year":"2009","unstructured":"Eckstein, N. et al. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. Cancer research 69, 2996\u20133003, doi: 10.1158\/0008-5472.CAN-08-3153 (2009).","journal-title":"Cancer research"},{"key":"BFsrep36612_CR6","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1158\/1078-0432.CCR-09-3233","volume":"16","author":"GS Huang","year":"2010","unstructured":"Huang, G. S. et al. Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 16, 2999\u20133010, doi: 10.1158\/1078-0432.CCR-09-3233 (2010).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep36612_CR7","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1038\/onc.2010.7","volume":"29","author":"S Eliasz","year":"2010","unstructured":"Eliasz, S. et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 29, 2488\u20132498, doi: 10.1038\/onc.2010.7 (2010).","journal-title":"Oncogene"},{"key":"BFsrep36612_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1084\/jem.20110121","volume":"208","author":"H Medyouf","year":"2011","unstructured":"Medyouf, H. et al. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. The Journal of experimental medicine 208, 1809\u20131822, doi: 10.1084\/jem.20110121 (2011).","journal-title":"The Journal of experimental medicine"},{"key":"BFsrep36612_CR9","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1038\/onc.2012.290","volume":"32","author":"WK Chau","year":"2013","unstructured":"Chau, W. K., Ip, C. K., Mak, A. S., Lai, H. C. & Wong, A. S. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt\/beta-catenin-ATP-binding cassette G2 signaling. Oncogene 32, 2767\u20132781, doi: 10.1038\/onc.2012.290 (2013).","journal-title":"Oncogene"},{"key":"BFsrep36612_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero, A. B. et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell cycle 8, 158\u2013166, doi: 10.4161\/cc.8.1.7533 (2009).","journal-title":"Cell cycle"},{"key":"BFsrep36612_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2001-1326-2-3","volume":"2","author":"LN Abdullah","year":"2013","unstructured":"Abdullah, L. N. & Chow, E. K.-H. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med 2, 3, doi: 10.1186\/2001-1326-2-3 (2013).","journal-title":"Clin Transl Med"},{"key":"BFsrep36612_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nature reviews. Cancer 5, 275\u2013284, doi: 10.1038\/nrc1590 (2005).","journal-title":"Nature reviews. Cancer"},{"key":"BFsrep36612_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2014.11.040","volume":"357","author":"A Wang","year":"2015","unstructured":"Wang, A., Chen, L., Li, C. & Zhu, Y. Heterogeneity in cancer stem cells. Cancer letters 357, 63\u201368, doi: 10.1016\/j.canlet.2014.11.040 (2015).","journal-title":"Cancer letters"},{"key":"BFsrep36612_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328\u2013337, doi: 10.1038\/nature12624 (2013).","journal-title":"Nature"},{"key":"BFsrep36612_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang, D. G. Understanding cancer stem cell heterogeneity and plasticity. Cell research 22, 457\u2013472, doi: 10.1038\/cr.2012.13 (2012).","journal-title":"Cell research"},{"key":"BFsrep36612_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell stem cell 1, 555\u2013567, doi: 10.1016\/j.stem.2007.08.014 (2007).","journal-title":"Cell stem cell"},{"key":"BFsrep36612_CR17","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","volume":"67","author":"D Beier","year":"2007","unstructured":"Beier, D. et al. CD133(+) and CD133(\u2212) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer research 67, 4010\u20134015, doi: 10.1158\/0008-5472.CAN-06-4180 (2007).","journal-title":"Cancer research"},{"key":"BFsrep36612_CR18","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1002\/cncr.26215","volume":"117","author":"F Casagrande","year":"2011","unstructured":"Casagrande, F. et al. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer 117, 5519\u20135528, doi: 10.1002\/cncr.26215 (2011).","journal-title":"Cancer"},{"key":"BFsrep36612_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.canlet.2014.08.023","volume":"354","author":"RK Singh","year":"2014","unstructured":"Singh, R. K. et al. IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells. Cancer letters 354, 254\u2013262, doi: 10.1016\/j.canlet.2014.08.023 (2014).","journal-title":"Cancer letters"},{"key":"BFsrep36612_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.biocel.2015.02.001","volume":"61","author":"SM Gaikwad","year":"2015","unstructured":"Gaikwad, S. M., Thakur, B., Sakpal, A., Singh, R. K. & Ray, P. Differential activation of NF-kappaB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. The international journal of biochemistry & cell biology 61, 90\u2013102, doi: 10.1016\/j.biocel.2015.02.001 (2015).","journal-title":"The international journal of biochemistry & cell biology"},{"key":"BFsrep36612_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/stem.582","volume":"29","author":"KW Broadley","year":"2011","unstructured":"Broadley, K. W. et al. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem cells 29, 452\u2013461, doi: 10.1002\/stem.582 (2011).","journal-title":"Stem cells"},{"key":"BFsrep36612_CR22","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.4161\/cc.10.14.16418","volume":"10","author":"LS Hart","year":"2014","unstructured":"Hart, L. S. et al. Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle 10, 2331\u20132338, doi: 10.4161\/cc.10.14.16418 (2014).","journal-title":"Cell Cycle"},{"key":"BFsrep36612_CR23","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/bcr3423","volume":"15","author":"WW Chang","year":"2013","unstructured":"Chang, W. W. et al. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem\/progenitors. Breast cancer research: BCR 15, R39, doi: 10.1186\/bcr3423 (2013).","journal-title":"Breast cancer research: BCR"},{"key":"BFsrep36612_CR24","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/1535-7163.MCT-13-0091","volume":"12","author":"X Wu","year":"2013","unstructured":"Wu, X. et al. Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro. Molecular cancer therapeutics 12, 1526\u20131536, doi: 10.1158\/1535-7163.MCT-13-0091 (2013).","journal-title":"Molecular cancer therapeutics"},{"key":"BFsrep36612_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ghir.2010.09.005","volume":"20","author":"Y Li","year":"2010","unstructured":"Li, Y. & Geng, Y.-J. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation. Growth Hormone & IGF Research 20, 391\u2013398, doi: 10.1016\/j.ghir.2010.09.005 (2010).","journal-title":"Growth Hormone & IGF Research"},{"issue":"8","key":"BFsrep36612_CR26","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/bjc.2014.25","volume":"110","author":"J J Ko","year":"2014","unstructured":"Koussounadis, A., Langdon, S., Harrison, D. & Smith, V. A. Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer. British journal of cancer, doi: 10.1038\/bjc.2014.258 (2014).","journal-title":"British Journal of Cancer"},{"key":"BFsrep36612_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang, W. & Liu, H. T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell research 12, 9\u201318, doi: 10.1038\/sj.cr.7290105 (2002).","journal-title":"Cell research"},{"key":"BFsrep36612_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/hep.25745","volume":"56","author":"J Shan","year":"2012","unstructured":"Shan, J. et al. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology 56, 1004\u20131014, doi: 10.1002\/hep.25745 (2012).","journal-title":"Hepatology"},{"key":"BFsrep36612_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.cr.7290105","volume":"4","author":"A-M Bleau","year":"2009","unstructured":"Bleau, A.-M. et al. PTEN\/PI3K\/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell stem cell 4, 226\u2013235, doi: 10.1038\/sj.cr.7290105 (2009).","journal-title":"Cell stem cell"},{"key":"BFsrep36612_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00403-010-1100-1","volume":"303","author":"S Geng","year":"2011","unstructured":"Geng, S. et al. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431. Archives of dermatological research 303, 181\u2013189, doi: 10.1007\/s00403-010-1100-1 (2011).","journal-title":"Archives of dermatological research"},{"key":"BFsrep36612_CR31","unstructured":"Goodell, M. A., McKinney-Freeman, S. & Camargo, F. D. in Basic Cell Culture Protocols 343\u2013352 (Springer, 2005)."},{"key":"BFsrep36612_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1634\/stemcells.2005-0282","volume":"24","author":"N Haraguchi","year":"2006","unstructured":"Haraguchi, N. et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem cells 24, 506\u2013513, doi: 10.1634\/stemcells.2005-0282 (2006).","journal-title":"Stem cells"},{"key":"BFsrep36612_CR33","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.0400067101","volume":"101","author":"C Hirschmann-Jax","year":"2004","unstructured":"Hirschmann-Jax, C. et al. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America 101, 14228\u201314233, doi: 10.1073\/pnas.0400067101 (2004).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep36612_CR34","doi-asserted-by":"publisher","first-page":"39550","DOI":"10.18632\/oncotarget.6098","volume":"6","author":"Z Huang","year":"2015","unstructured":"Huang, Z., Wu, T., Liu, A. Y. & Ouyang, G. Differentiation and transdifferentiation potentials of cancer stem cells. Oncotarget 6, 39550, doi: doi: 10.18632\/oncotarget.6098 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep36612_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/stem.1333","volume":"31","author":"Y Touil","year":"2013","unstructured":"Touil, Y. et al. The PI3K\/AKT Signaling Pathway Controls the Quiescence of the Low\u2010Rhodamine123\u2010Retention Cell Compartment Enriched for Melanoma Stem Cell Activity. Stem cells 31, 641\u2013651, doi: 10.1002\/stem.1333 (2013).","journal-title":"Stem cells"},{"key":"BFsrep36612_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tibs.2009.06.003","volume":"34","author":"J Kang","year":"2009","unstructured":"Kang, J., Shakya, A. & Tantin, D. Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends in biochemical sciences 34, 491\u2013499, doi: 10.1016\/j.tibs.2009.06.003 (2009).","journal-title":"Trends in biochemical sciences"},{"key":"BFsrep36612_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.stem.2011.09.010","volume":"9","author":"T Suda","year":"2011","unstructured":"Suda, T., Takubo, K. & Semenza, G. L. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell stem cell 9, 298\u2013310, doi: 10.1016\/j.stem.2011.09.010 (2011).","journal-title":"Cell stem cell"},{"key":"BFsrep36612_CR38","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","volume":"23","author":"M Koshiji","year":"2004","unstructured":"Koshiji, M. et al. HIF\u20101\u03b1 induces cell cycle arrest by functionally counteracting Myc. The EMBO journal 23, 1949\u20131956, doi: 10.1038\/sj.emboj.7600196 (2004).","journal-title":"The EMBO journal"},{"key":"BFsrep36612_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","volume":"19","author":"S Chandarlapaty","year":"2011","unstructured":"Chandarlapaty, S. et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer cell 19, 58\u201371, doi: 10.1016\/j.ccr.2010.10.031 (2011).","journal-title":"Cancer cell"},{"key":"BFsrep36612_CR40","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1634\/stemcells.2006-0567","volume":"25","author":"WG Telford","year":"2007","unstructured":"Telford, W. G., Bradford, J., Godfrey, W., Robey, R. W. & Bates, S. E. Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem cells 25, 1029\u20131036, doi: 10.1634\/stemcells.2006-0567 (2007).","journal-title":"Stem cells"},{"key":"BFsrep36612_CR41","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3892\/or.2012.1964","volume":"28","author":"Y Chen","year":"2012","unstructured":"Chen, Y., Zhu, C., Peng, Z., Dai, Y. & Gu, Y. Lentivirus-mediated short-hairpin RNA targeting IGF-1R inhibits growth and lymphangiogenesis in breast cancer. Oncol Rep 28, 1778\u20131784, doi: 10.3892\/or.2012.1964 (2012).","journal-title":"Oncol Rep"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep36612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36612","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:44:55Z","timestamp":1672879495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep36612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep36612"],"URL":"https:\/\/doi.org\/10.1038\/srep36612","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]},"assertion":[{"value":"14 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36612"}}